Ze-ping Zhou

Kunming, 650101, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia.

Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia.

Journal: The oncologist

Published: January 08, 2025

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.

Journal: Journal of cancer research and clinical oncology

Published: September 28, 2023

The novel HLA-A*68:302 allele, identified by Sanger dideoxynucleotide sequencing in a Chinese individual.

The novel HLA-A*68:302 allele, identified by Sanger dideoxynucleotide sequencing in a Chinese individual.

Journal: HLA

Published: June 07, 2023

Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.

Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.

Journal: American journal of hematology

Published: March 13, 2023

A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.

A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.

Journal: Science bulletin

Published: November 30, 2022

Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.

Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.

Journal: Blood advances

Published: February 02, 2022

Efficacy and safety of rituximab for minors with immune thrombocytopenia: a systematic review and meta-analysis.

Efficacy and safety of rituximab for minors with immune thrombocytopenia: a systematic review and meta-analysis.

Journal: The Journal of international medical research

Published: October 29, 2020

A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.

A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.

Journal: Blood advances

Published: July 30, 2020

Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.

Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.

Journal: Platelets

Published: July 03, 2020

Strategy changes in Chinese hematologists' diagnosis and treatment of primary immune thrombocytopenia across 10 years (2009-2018).

Strategy changes in Chinese hematologists' diagnosis and treatment of primary immune thrombocytopenia across 10 years (2009-2018).

Journal: Chinese medical journal

Published: November 15, 2019

Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Chinese guidelines for treatment of adult primary immune thrombocytopenia.

Journal: International journal of hematology

Published: November 28, 2017

MUC1-2VNTR DNA Vaccine Induces Immune Responses in Mouse Model with Multiple Myeloma

MUC1-2VNTR DNA Vaccine Induces Immune Responses in Mouse Model with Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: November 03, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026